Incidence of type 2 diabetes is increasing rapidly. It accounts for up to half of all cases of new-onset diabetes in young people. Dysfunction in glucose homeostasis impacts acid-base regulation. In addition, injury to organs as a result of diabetes and antidiabetic drugs contribute to this dysregulation. Hyponatremia is associated …
Read More »A Novel Formulation of Metformin May Increase the Drug’s Use
For newly diagnosed type 2 diabetes patients, metformin is the first-line drug of choice. It can be used alone, in combination with other oral antidiabetic drugs, or in addition to insulin. Its precise mechanism of action is as of yet unknown, but a new study published in Diabetes Care posits …
Read More »New Study Shows Metformin Resides in Gut, Not Circulation
Even though metformin delayed release resides in gut, it still maintains glucose-lowering effect… Metformin has been known to be the first line treatment for type 2 diabetes if the side effects are tolerable. According to new study published by Diabetes Care, metformin delayed release (metformin DR) primary effect is in …
Read More »Metformin’s Effect on Levothyroxine Absorption
Scientists still struggling to find exact mechanism responsible for altered TSH levels when taking drug… A recent study was published in Thyroid evaluating 26 healthy adults ages 18 to 50 years old who had no use of levothyroxine or metformin in the prior 3 months. They were looking to see …
Read More »Liver Disease Affects Metformin Metabolism
Increased diabetes drug exposure may increase risk of adverse reactions in type 2 patients with NASH… Obesity increases the risk of nonalcoholic steatohepatitis (NASH), which occurs when there is too much fat in the liver. NASH is often asymptomatic and because testing for it requires a liver biopsy, many cases …
Read More »Metformin During Pregnancy Does Not Lower Infant Birth Weight
Study finds diabetes drug does not prevent macrosomia when given to obese women during pregnancy…. Maternal obesity increases the risk of higher infant birth weights as well as complications such as preeclampsia, cesarean section delivery, maternal hemorrhage, infant mortality and stillbirth. Additionally, infants born with higher fat mass are at …
Read More »Metformin May Increase Mortality in Advanced CKD among Type 2 Patients
Recent study reported a significant increase in all-cause mortality associated with the use of metformin in patients with type 2 diabetes.
Read More »Effects of Metformin and Lifestyle Modification in Polycystic Ovarian Syndrome (PCOS)
Together with lifestyle modification, metformin lowered BMI and subcutaneous fat, and improved menstruation cycles… Excessive weight in PCOS is often linked to insulin resistance, impaired glucose tolerance, dyslipidemia, high androgen levels, ovulation dysfunction, and subfertility. Insulin resistance is regarded as the key feature of PCOS, thus most women suffering from …
Read More »Metformin May Reduce the Risk of Developing Glaucoma
Patients taking metformin during a 10-year study had a 25% reduced risk of developing glaucoma… The researchers hypothesized that a drug that mimics caloric restriction, such as metformin, might reduce the risk of glaucoma, said Julia Richards, lead researcher and ophthalmology professor at the University of Michigan Ann Arbor. Richards …
Read More »Patient’s Plan to “Stop All of My Medicine” Not a Good Idea…
The patient, a woman, 52 years of age, has type 2 diabetes and is on metformin, a GLP-1 agonist, and a long-acting insulin. Over the past few months, I’ve received calls and emails from her every now and then to let me know her glucose levels were rising, but whenever …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.